Boston Scientific (BSX) Revenue Growth (1y) (2010 - 2026)
Boston Scientific (BSX) Revenue Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 7.78% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 2.63% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 8.74% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 11.58% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 16.70% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.08% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 15.05% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 7.41% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 7.29% |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | 9.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.58% |
| Dec 31, 2025 | 15.90% |
| Sep 30, 2025 | 20.34% |
| Jun 30, 2025 | 22.84% |
| Mar 31, 2025 | 20.93% |
| Dec 31, 2024 | 22.44% |
| Sep 30, 2024 | 19.34% |
| Jun 30, 2024 | 14.48% |
| Mar 31, 2024 | 13.78% |
| Dec 31, 2023 | 14.90% |
| Sep 30, 2023 | 11.26% |
| Jun 30, 2023 | 10.94% |
| Mar 31, 2023 | 12.00% |
| Dec 31, 2022 | 3.68% |
| Sep 30, 2022 | 8.12% |
| Jun 30, 2022 | 5.43% |
| Mar 31, 2022 | 9.96% |
| Dec 31, 2021 | 15.43% |
| Sep 30, 2021 | 10.27% |
| Jun 30, 2021 | 53.62% |